The International Breast Pathology Symposium (IBPS 2025), hosted at Cleveland Clinic Abu Dhabi in collaboration with the Association of Breast Pathology (ABP), convened global experts and senior clinicians to examine emerging developments in breast cancer diagnostics, prognostication, and personalized therapeutic decision-making. The two-day program, accredited with 11.35 CME points by the Department of Health (DoH), provided a rigorous platform for peer engagement, evidence-based discourse, and translational research exchange.
